You searched for dna - Page 24 of 40

Best in Biotech 19 Aug 2020

7 Biotech Books to Read in the Sun this Summer

…of its discoverers In A Crack in Creation, Jennifer Doudna and former colleague Samuel Sternberg share the story behind the discovery of CRISPR, a technology that makes gene editing way…

August 19, 2020 - 4 minutesmins - By Clara Rodríguez Fernández

colorectal cancer mologen cancer immunotherapy

News and Trends 6 Dec 2019

Update: Cancer Immunotherapy Biotech Files for Insolvency

Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in the summer, the German company Mologen has filed for insolvency. Published 06/08/2019 A DNA immunotherapy…

December 6, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 1 Jul 2025

Is an HIV cure possible? The future of HIV therapy

…the U.S. within two years. These drugs work by interfering with key steps in HIV’s replication process, for example, blocking the enzyme that converts viral RNA into DNA, or preventing…

July 1, 2025 - 11 minutesmins - By Jules Adam

CRISPR Therapeutics, CRISPR-Cas9, genome editing, biotech

News and Trends 17 Oct 2022

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

…greatest scientific advancements of the last 100 years. In 2012, Jennifer Doudna and Emanuelle Charpentier published a peer-reviewed paper discussing the use of CRISPR/Cas9 in gene editing. They probably didn’t…

October 17, 2022 - 6 minutesmins - By External Contributor

Best in Biotech 7 Mar 2024

6 biotech companies tackling antibiotic resistance

…focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates that block a new molecular target called DNA polymerase…

March 7, 2024 - 8 minutesmins - By Willow Shah-Neville

Covid 19 manufacturing vaccine therapies antibody

News and Trends 9 Dec 2020

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

…a pandemic has been challenging to say the least.” Touchlight DNA services, the contract manufacturing arm of UK biotech Touchlight Genetics, aims to support Covid-19 drug and vaccine manufacture by…

December 9, 2020 - 5 minutesmins - By Helen Albert

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

…vaccine development include improving the manufacture, supply, and distribution of Covid-19 vaccines. Additionally, improving vaccine access in these regions could reduce the likelihood of dangerous variants emerging. DNA vaccines are…

February 15, 2022 - 7 minutesmins - By Jonathan Smith

Best in Biotech 15 Mar 2023

7 biotechs in Hungary you should know about

…protein CDC7 contributes to DNA replication in cells, however, its overexpression has been regarded as a marker in cancers like colorectal cancer. CDC7 inhibitors target the enzyme CDC7 kinase, which…

March 15, 2023 - 9 minutesmins - By Alex Dale

News and Trends 4 Oct 2021

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

…in development include delivering DNA to tissues via electric currents, as developed by the Parisian firm Eyevensys, and transfection, a technology that relies on small DNA molecules called plasmids to…

October 4, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 15 Jul 2016

These Two ‘Omics’ Companies are Merging to Create a New Player in Life Sciences

…end of the article for more details. Headquartered in Germany and Spain, Sygnis develops products for genomic research, such as kits to amplify DNA and systems to ‘convert’ RNA into…

July 15, 2016 - 4 minutesmins - By Denise Neves Gameiro

In Depth 4 Nov 2020

The Return of Gene Therapy

…DNA sequences into patients’ cells for treating people with genetic disorders. However, they urged caution in the development of the technology, pointing out several key bottlenecks in scientific understanding that…

November 4, 2020 - 8 minutesmins - By Farhan Mitha

News and Trends 24 Feb 2017

What are the Current Challenges in the Booming Field of ADCs?

…the minor groove of DNA. The optimally snug fit makes Tesirine the most effective cross-linking agent that is thereby able to damage DNA and induce cell death. On the left,…

February 24, 2017 - 5 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: dna

7 Biotech Books to Read in the Sun this Summer

Update: Cancer Immunotherapy Biotech Files for Insolvency

Is an HIV cure possible? The future of HIV therapy

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

6 biotech companies tackling antibiotic resistance

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

7 biotechs in Hungary you should know about

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

These Two ‘Omics’ Companies are Merging to Create a New Player in Life Sciences

The Return of Gene Therapy

What are the Current Challenges in the Booming Field of ADCs?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!